Evidence map›Paper›PMID 26713223›Full record

ReviewBacteriophage

Bacteriophage remediation of bacterial pathogens in aquaculture: a review of the technology.

Gary P Richards

Open access · hybridAbstract readReview
In one paragraph

Review in Bacteriophage. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 131 citations in OpenAlex.

  1. Bacteriophages AgainstViruses · 2026
    Review
  2. Biology · 2026
    Article
  3. Review
  4. A novel phage vB_VhaM_HVS-1 inhibits host cell associatedFrontiers in veterinary science · 2026
    Article
  5. Article
  6. Review
  7. Bacteriophage-based strategies for biocontrol and treatment of infectious diseases.Computational and structural biotechnology journal · 2025
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Characterization of a Vibriophage Infecting PathogenicInternational journal of molecular sciences · 2023
    Article
  13. Food science and biotechnology · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Strategies for managing marine disease.Ecological applications : a publication of the Ecological Society of America · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Gary P RichardsUnited States Department of Agriculture; Agricultural Research Service; Delaware State University ; Dover, DE USA.
Delaware State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages have been proposed as an alternative to antibiotic usage and several studies on their application in aquaculture have been reported. This review highlights progress to date on phage therapies for the following fish and shellfish diseases and associated pathogens: hemorrhagic septicemia (Aeromonas hydrophila) in loaches, furunculosis (Aeromonas salmonicida) in trout and salmon, edwardsiellosis (Edwardsiella tarda) in eel, columnaris disease (Flavobacterium columnare) in catfish, rainbow trout fry syndrome or cold water disease (Flavobacterium psychrophilum) in trout and salmon, lactococcosis (Lactococcus spp.) in yellowtail, ulcerative skin lesions (Pseudomonas aeruginosa) in freshwater catfish, bacterial hemorrhagic ascites disease (Pseudomonas plecoglossicida) in ayu fish, streptococcosis (Streptococcus iniae) in flounder, and luminescent vibriosis (Vibrio harveyi) in shrimp. Information is reviewed on phage specificity, host resistance, routes of administration, and dosing of fish and shellfish. Limitations in phage research are described and recommended guidelines are provided for conducting future phage studies involving fish and shellfish.

Indexed as

aquaculturebacterial infectionsfish diseasemariculturephage therapyshellfish

Identifiers

PMID26713223
PMCPMC4590005
OpenAlexW2091220627

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.